Results 51 to 60 of about 6,111 (204)
Subtyping treatment response of tirofiban in acute ischemic stroke based on neuroimaging features
In a previously published clinical trial, we demonstrated that tirofiban was effective and safe in acute ischemic stroke (AIS) patients who did not undergo early recanalization treatments.
Bin Han+7 more
doaj +1 more source
Safety of tirofiban and dual antiplatelet therapy in treating intracranial aneurysms
Background Endovascular treatment of intracranial aneurysms usually involves stent-assisted coiling (SAC) and flow diverters. Glycoprotein IIb/IIIa inhibitors such as tirofiban and dual antiplatelet therapy (DAPT) are required to prevent thromboembolic ...
David M Hasan+7 more
doaj +1 more source
Safety of Tirofiban in Acute Ischemic Stroke [PDF]
Background and Purpose— Tirofiban is a highly selective, fast-acting nonpeptide glycoprotein IIb/IIIa platelet receptor antagonist with a short half-life time. Glycoprotein IIb/IIIa antagonists are effective for the treatment of acute coronary syndromes proven in large clinical trials.
Siebler, M.+10 more
openaire +4 more sources
Efficacy and Safety of Intracoronary versus Intravenous Administration of Tirofiban during Percutaneous Coronary Intervention for Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials. [PDF]
Percutaneous coronary intervention (PCI) is known as the most effective treatment for acute coronary syndrome (ACS). However, without proper therapy and patient management, stent thrombosis after PCI may lead to another myocardial infarction. In addition
Xiuying Tang+4 more
doaj +1 more source
Tirofiban induced diffuse alveolar hemorrhage
Alveolar hemorrhage is a dreaded complication which is seen rarely following the use of tirofiban, it is often confused with other respiratory syndromes resulting in inappropriate or delayed treatment. We present a case of acute alveolar hemorrhage following tirofiban infusion following acute coronary syndrome.
Deepak Kadeli+3 more
openaire +3 more sources
Abstract Background and Purpose Flow diversion has become a key treatment option for complex intracranial aneurysms. Recent advancements include coated flow diverters (FDs), designed to potentially reduce the need for dual antiplatelet therapy, thereby removing the associated secondary risks while maintaining patency and low complication rates ...
Daniel Weiss+7 more
wiley +1 more source
Abstract Background While advances in endovascular thrombectomy (EVT) have led to high reperfusion rates, most patients treated with EVT do not avoid disability. Post‐reperfusion hemorrhagic transformation (HT) is a potential target for improving outcomes.
Richard Leigh+24 more
wiley +1 more source
Influence of TyG Index on Large Vascular Occlusive Stroke Following Endovascular Treatment
This single‐center retrospective cohort study indicates that the triglyceride‐glucose index (TyG index), as a marker of insulin resistance, was significantly linked to worse functional outcome, increased mortality at 90 days, and a higher risk of symptomatic intracranial hemorrhage (sICH) in patients with acute ischemic stroke postendovascular ...
Wei Sun+7 more
wiley +1 more source
RACIONAL: A lesão de isquemia e reperfusão hepática é um evento comum e responsável por considerável morbidade e mortalidade. OBJETIVO: Avaliar efeitos de inibidor da glicoproteína IIb/IIIa, cloridrato de tirofiban, nas alterações hepáticas e pulmonares ...
Leonardo F. Canedo+5 more
doaj +1 more source
Key Clinical Message Coronary artery aneurysm (CAA), marked by diffuse or localized dilation of artery, can cause life‐threatening complications in acute coronary syndrome. This report presents a case of CAA combined with acute ST‐segment elevation myocardial infarction, successfully treated with cardiac rehabilitation exercise therapy, offering ...
Xin‐di Feng+4 more
wiley +1 more source